Abstract

Pediatric hematology is seeing rapid advancements in diagnostics and therapies across various conditions. This includes progress
in treating malignancies like leukemias with CAR T-cells, emerging gene therapies for hemophilia and Sickle Cell Disease, and
improved management for Iron Deficiency Anemia and Immune Thrombocytopenia. Genetic insights are reshaping approaches to
Myelodysplastic Syndromes and Fanconi anemia, while tailored treatments improve outcomes for aplastic anemia. Comprehensive
strategies for conditions like neutropenia underscore the focus on personalized, effective care to enhance the lives of young patients.